Search Results - "Laban S"

Intraoperative use of virtual reality decreases anxiety during surgery under local anaesthesia in the head and neck region.

Authors: Tippelt, L. Sommer, F. Schmid, S. et al.

Source: Virtual Reality; Dec2024, Vol. 28 Issue 4, p1-12, 12p

COMMUNITY PHARMACISTS' PERCEPTIONS AND KNOWLEDGE OF COMPLEMENTARY AND ALTERNATIVE MEDICINES (CAM) IN KADUNA, NIGERIA.

Authors: Ma'aji, H. U. Auwal, F. I. Laban, S. et al.

Source: Bayero Journal of Pure & Applied Sciences; 2019 Special Issue, Vol. 12, p112-116, 5p

1441TiP An open-label, phase Ib trial to assess the safety and efficacy of SIRPα monoclonal antibody BI 770371 in combination with pembrolizumab with or without cetuximab compared with pembrolizumab monotherapy for the first-line treatment of patients with head and neck squamous cell carcinoma (NCT06806852)

Authors: Laban, S. Osinowo, S. Hu, C. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS874-S875. 2p.

This result is not displayed to guests.
Login for full access.

Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients.

Authors: Theodoraki, M.-N. Laban, S. Jackson, E. K. et al.

Source: British Journal of Cancer. Dec2021, Vol. 125 Issue 12, p1677-1686. 10p.

VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study.

Authors: Metcalf, R. Laban, S. Kristensen, C.A. et al.

Source: Annals of Oncology. Aug2024, Vol. 35 Issue 8, p754-755. 2p.

Lack of De‐Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis.

Authors: Vahl, J. M. Hahn, J. von Witzleben, A. et al.

Source: Cancer Medicine. Mar2026, Vol. 15 Issue 3, p1-10. 10p.

915P Longer OS and RFS for CD3high/PD-L1+ head and neck squamous cell carcinoma (HNSCC) patients.

Authors: Laban, S. Remark, R. Idel, C. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS643-S643. 1p.

New treatment strategies for HPV-positive head and neck cancer.

Authors: Kofler, B. Laban, S. Busch, C. et al.

Source: European Archives of Oto-Rhino-Laryngology. Jul2014, Vol. 271 Issue 7, p1861-1867. 7p.

Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up.

Authors: Möckelmann, N. Laban, S. Pantel, K. et al.

Source: European Archives of Oto-Rhino-Laryngology. Jan2014, Vol. 271 Issue 1, p15-21. 7p.

New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011.

Authors: Mumme, A. Laban, S. Knecht, R.

Source: European Archives of Oto-Rhino-Laryngology. Nov2012, Vol. 269 Issue 11, p2303-2308. 6p.

878P INHBA is overexpressed in HPV-negative oropharyngeal squamous cell carcinoma and contributes to an aggressive phenotype.

Authors: Laban, S. Hofmann, L. Betzler, A.C. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS565-S565. 1p.

27P Plasma-derived exosomes as biomarkers for therapy monitoring in head and neck cancer patients treated with surgery and (chemo)radiotherapy.

Authors: Hofmann, L. Laban, S. Jackson, E.K. et al.

Source: Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1385-S1385. 1p.

Globusgefühl und Hustenreiz durch ein gestieltes Lymphom im Bereich des Waldeyer'schen Rachenrings.

Authors: Laban, S. Mnscher, A. Habermann, C. R. et al.

Source: GMS Current Posters in Otorhinolaryngology: Head & Neck Surgery. 2011, Vol. 7, p1-1. 1p. 2 Color Photographs, 1 Black and White Photograph.

Beidseitige Recurrensparese als initiales Symptom eines perilaryngeal metastasierten, klarzelligen Nierenzellkarzinom.

Authors: Laban, S. Münscher, A. Habermann, C. et al.

Source: GMS Current Posters in Otorhinolaryngology: Head & Neck Surgery. 2010, Vol. 6, p1-1. 1p. 1 Color Photograph, 1 Black and White Photograph.

1084PMultiobjective optimization reveals distinct cancer-testis antigen patterns by primary site and human papilloma virus status in head and neck squamous cell carcinoma.

Authors: Laban, S Völkel, G Ezic, J et al.

Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Systematische Nachsorge bei Patienten mit Kopf-Hals-Tumoren.

Alternate Title: Systematic oncological follow-up in patients with head and neck cancer.

Authors: Böhm, F. Schlötzer, W. Deininger, K. et al.

Source: Best Practice Onkologie. Jul2023, Vol. 18 Issue 7/8, p296-305. 10p.

4 Immune response evaluation to curative conventional therapy – The IRECT trial.

Authors: Laban, S. Atanackovic, D. Lütkens, T. et al.

Source: Oral Oncology. May2015, Vol. 51 Issue 5, pe28-e29. 1p.

Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma.

Authors: Jeske, S. S. Schuler, P. J. Doescher, J. et al.

Source: Immunity & Ageing. 2/12/2020, Vol. 17 Issue 1, p1-11. 11p.

Response Evaluation in Head and Neck Oncology: Definition and Prediction.

Authors: Hoffmann, T.K. Schuler, P.J. Laban, S. et al.

Source: ORL (0301-1569). Feb2017, Vol. 79 Issue 1/2, p14-23. 10p.